The first Zymergen trade was made in Q2 2021.
Since then Ken Griffin bought shares two more times and sold shares on four occasions. The investor completely sold their stake between Q2 2022 and Q4 2022.
Avg closing price
Price range
Sold -23.3 Thousand shares
Q4 2022
Avg closing price
$2.67
Price range
$2.35
-
$3.14
Sold 90.8% shares (-231 Thousand shares)
Q3 2022
Avg closing price
$2.43
Price range
$1.20
-
$3.37
Sold 59.1% shares (-367 Thousand shares)
Q2 2022
Avg closing price
$1.68
Price range
$1.12
-
$3.03
Increased shares by 98.3% (+308 Thousand shares)
Q1 2022